Diabetes Mellitus, Non-Insulin-Dependent Clinical Trial
Official title:
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA (OPTIMISE)
OPTIMISE-CEEMEA is a multinational, multi-centre, observational, prospective study which
will include patients suffering from diabetes type 2, treated or untreated, insulin
dependent or not insulin dependent.
In this study we aim to explore at a primary care level whether the use of benchmarking
against a set of guideline-based reference values on a patient basis, may improve quality of
patient care, in particular control of diabetes, lipids and blood pressure.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02801448 -
Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes
|
Phase 2 | |
Withdrawn |
NCT01377961 -
Effect of Lycopene and Isoflavones on Glucose Metabolism
|
N/A | |
Completed |
NCT00754130 -
MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).
|
Phase 1 | |
Completed |
NCT00006305 -
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT00004983 -
Education and Group Support for Diabetic Hispanics
|
N/A | |
Completed |
NCT00010751 -
Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors
|
Phase 2 | |
Completed |
NCT02299388 -
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
|
Phase 4 | |
Completed |
NCT00550329 -
Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
|
Phase 1 | |
Completed |
NCT00172536 -
Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft
|
N/A | |
Completed |
NCT00071422 -
Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes
|
Phase 2 | |
Completed |
NCT00029848 -
Obese Patients With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT01608724 -
The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT00979368 -
Safety Study of BMS-816336 in Healthy Male Subjects
|
Phase 1 | |
Completed |
NCT00791661 -
MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)
|
Phase 1 | |
Active, not recruiting |
NCT02088658 -
Technology Intensified Diabetes Education Study in African Americans
|
N/A | |
Completed |
NCT01105429 -
Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
|
Phase 1 | |
Completed |
NCT00701090 -
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
|
Phase 3 | |
Completed |
NCT00952991 -
The Effects of LAF237 on Gastric Function in Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT00035984 -
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT00044447 -
Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione
|
Phase 3 |